BridgeBio Pharma, Inc. (BBIO)

78.33 -0.78 (-0.99%) USD  |  NASDAQ  |  Jan 14, 12:40
More

BridgeBio Pharma Non-Current Deferred Liabilities (Quarterly)

Non-Current Deferred Liabilities (Quarterly) Chart

View Non-Current Deferred Liabilities (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Liabilities (Quarterly) Benchmarks

View Non-Current Deferred Liabilities (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --
Supernus Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade